Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Observational Study of Patients With Chronic Liver Disease
Sponsor: Target PharmaSolutions, Inc.
Summary
TARGET-Liver Disease (TARGET-LD) is an observational research study to conduct a comprehensive review of outcomes for patients with chronic liver disease (CLD).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500000
Start Date
2024-02-19
Completion Date
2037-12-31
Last Updated
2026-03-03
Healthy Volunteers
No
Conditions
Interventions
Observational
Observational
Locations (10)
Keck School of Medicine of USC
Los Angeles, California, United States
Stanford Medicine
Redwood City, California, United States
Georgetown Medstar Transplant Institute
Washington D.C., District of Columbia, United States
Rush University Medical Center
Chicago, Illinois, United States
Columbia University Irving Medical Center/ New York Presbyterian Hospital
New York, New York, United States
Atrium Health Center for Liver Disease and Transplant
Charlotte, North Carolina, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Temple University - Lewis Katz School of Medicine
Philadelphia, Pennsylvania, United States
Baylor Scott & White Research Institute
Dallas, Texas, United States
Baylor College of Medicine
Houston, Texas, United States